TGF-β and Cell Cycle Arrest in Gastric Cancer Cells
Author Information
Author(s): Kang S H, Bang Y-J, Jong H-S, Seo J Y, Kim N K, Kim S-J
Primary Institution: Cancer Research Center, and Department of Internal Medicine, Seoul National University College of Medicine
Hypothesis
Does TGF-β induce cell cycle arrest in gastric carcinoma cells through specific cdk inhibitors?
Conclusion
The study found that p21 plays an early role in TGF-β-induced cell cycle arrest, while Cdc25A down-regulation is delayed.
Supporting Evidence
- p21 mRNA was rapidly induced by TGF-β in less than 1 hour.
- Cdc25A mRNA down-regulation was delayed compared to p21.
- The study used two gastric carcinoma cell lines to assess the effects of TGF-β.
Takeaway
When certain stomach cancer cells are treated with TGF-β, a protein called p21 helps stop the cells from growing quickly, but another protein, Cdc25A, takes longer to decrease.
Methodology
The study used two TGF-β-sensitive gastric carcinoma cell lines to compare the expression patterns of cdk inhibitors and Cdc25A in response to TGF-β.
Participant Demographics
Two gastric carcinoma cell lines (SNU-16 and SNU-620)
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website